Last updated on August 2018

Evaluation of the Safety and Efficacy of GB-0998 in Unexplained Primary Recurrent Miscarriage


Brief description of study

To estimate the safety and efficacy of intravenous immunoglobulin therapy using GB-0998 in women with four or more miscarriages by carrying out randomized, placebo-controlled, double-blinded study

Clinical Study Identifier: NCT02184741

Find a site near you

Start Over